International Stem Cell (ISCO) Operating Leases (2019 - 2025)
Historic Operating Leases for International Stem Cell (ISCO) over the last 8 years, with Q3 2025 value amounting to $103000.0.
- International Stem Cell's Operating Leases fell 4926.11% to $103000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $103000.0, marking a year-over-year decrease of 4926.11%. This contributed to the annual value of $115000.0 for FY2024, which is 7415.73% down from last year.
- Per International Stem Cell's latest filing, its Operating Leases stood at $103000.0 for Q3 2025, which was down 4926.11% from $204000.0 recorded in Q2 2025.
- International Stem Cell's 5-year Operating Leases high stood at $950000.0 for Q4 2021, and its period low was $103000.0 during Q3 2025.
- Its 5-year average for Operating Leases is $532315.8, with a median of $588000.0 in 2023.
- In the last 5 years, International Stem Cell's Operating Leases surged by 2108.53% in 2022 and then tumbled by 7415.73% in 2024.
- Quarter analysis of 5 years shows International Stem Cell's Operating Leases stood at $950000.0 in 2021, then decreased by 24.21% to $720000.0 in 2022, then plummeted by 38.19% to $445000.0 in 2023, then tumbled by 74.16% to $115000.0 in 2024, then decreased by 10.43% to $103000.0 in 2025.
- Its last three reported values are $103000.0 in Q3 2025, $204000.0 for Q2 2025, and $302000.0 during Q1 2025.